Literature DB >> 16844314

Recursive causality in evolution: a model for epigenetic mechanisms in cancer development.

A Haslberger1, F Varga, H Karlic.   

Abstract

Interactions between adaptative and selective processes are illustrated in the model of recursive causality as defined in Rupert Riedl's systems theory of evolution. One of the main features of this theory also termed as theory of evolving complexity is the centrality of the notion of 'recursive' or 'feedback' causality - 'the idea that every biological effect in living systems, in some way, feeds back to its own cause'. Our hypothesis is that "recursive" or "feedback" causality provides a model for explaining the consequences of interacting genetic and epigenetic mechanisms which are known to play a key role in development of cancer. Epigenetics includes any process that alters gene activity without changes of the DNA sequence. The most important epigenetic mechanisms are DNA-methylation and chromatin remodeling. Hypomethylation of so-called oncogenes and hypermethylation of tumor suppressor genes appear to be critical determinants of cancer. Folic acid, vitamin B12 and other nutrients influence the function of enzymes that participate in various methylation processes by affecting the supply of methyl groups into a variety of molecules which may be directly or indirectly associated with cancerogenesis. We present an example from our own studies by showing that vitamin D3 has the potential to de-methylate the osteocalcin-promoter in MG63 osteosarcoma cells. Consequently, a stimulation of osteocalcin synthesis can be observed. The above mentioned enzymes also play a role in development and differentiation of cells and organisms and thus illustrate the close association between evolutionary and developmental mechanisms. This enabled new ways to understand the interaction between the genome and environment and may improve biomedical concepts including environmental health aspects where epigenetic and genetic modifications are closely associated. Recent observations showed that methylated nucleotides in the gene promoter may serve as a target for solar UV-induced mutations of the p53 tumor suppressor gene. This illustrates the close interaction of genetic and epigenetic mechanisms in cancerogenesis resulting from changes in transcriptional regulation and its contribution to a phenotype at the micro- or macroevolutionary level. Above-mentioned interactions of genetic and epigenetic mechanisms in oncogenesis defy explanation by plain linear causality, things like the continuing adaptability of complex systems. They can be explained by the concept of recursive causality and has introduced molecular biology into the realm of cognition science and systems theory: based on the notion of so-called feedback- or recursive causality a model for epigenetic mechanisms with relevance for oncology and biomedicine is provided.

Entities:  

Mesh:

Year:  2006        PMID: 16844314     DOI: 10.1016/j.mehy.2006.05.047

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  10 in total

Review 1.  [Tumor stem cell research - basis and challenge for diagnosis and therapy].

Authors:  Heidrun Karlic; Harald Herrmann; Axel Schulenburg; Thomas W Grunt; Sylvia Laffer; Irina Mirkina; Rainer Hubmann; Medhat Shehata; Brigitte Marian; Edgar Selzer; Michael Pfeilstöcker; Elisabeth Pittermann; Ulrich Jäger; Hubert Pehamberger; Christoph Zielinski; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2010-07-22       Impact factor: 1.704

Review 2.  Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention.

Authors:  B Stefanska; H Karlic; F Varga; K Fabianowska-Majewska; Ag Haslberger
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 3.  A simple guide to chaos and complexity.

Authors:  Dean Rickles; Penelope Hawe; Alan Shiell
Journal:  J Epidemiol Community Health       Date:  2007-11       Impact factor: 3.710

Review 4.  Pathology to enhance precision medicine in oncology: lessons from landscape ecology.

Authors:  Mark C Lloyd; Katarzyna A Rejniak; Joel S Brown; Robert A Gatenby; Emily S Minor; Marilyn M Bui
Journal:  Adv Anat Pathol       Date:  2015-07       Impact factor: 3.875

5.  The influence of DNA sequence on epigenome-induced pathologies.

Authors:  Richard B Meagher; Kristofer J Müssar
Journal:  Epigenetics Chromatin       Date:  2012-07-20       Impact factor: 4.954

6.  Impact of vitamin D metabolism on clinical epigenetics.

Authors:  Heidrun Karlic; Franz Varga
Journal:  Clin Epigenetics       Date:  2011-02-08       Impact factor: 6.551

7.  Epigenetics and the power of art.

Authors:  Heidrun Karlic; Pia Baurek
Journal:  Clin Epigenetics       Date:  2011-04-15       Impact factor: 6.551

8.  A systematic approach to cancer: evolution beyond selection.

Authors:  William B Miller; John S Torday
Journal:  Clin Transl Med       Date:  2017-01-03

Review 9.  Vitamin D: a critical and essential micronutrient for human health.

Authors:  Igor Bendik; Angelika Friedel; Franz F Roos; Peter Weber; Manfred Eggersdorfer
Journal:  Front Physiol       Date:  2014-07-11       Impact factor: 4.566

Review 10.  Darwin, medicine and cancer.

Authors:  A D Purushotham; R Sullivan
Journal:  Ann Oncol       Date:  2009-11-25       Impact factor: 32.976

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.